LisaBomgaarsMD

Pediatric Hematology & Oncology • Houston, TX

Associate Professor, Pediatric Hematology & Oncology, Baylor College of Medicine

Join to view full profile

Dr. Bomgaars is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bomgaars' full profile

Already have an account?

Office
6701 Fannin St
Houston, TX 77030
Phone+1 832-822-4240

Fax+1 832-825-4247

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1993 - 1997
Baylor College of Medicine (Houston)Residency, Pediatrics, 1990 - 1993
Ohio State University College of MedicineClass of 1990

Certifications & Licensure

TX State Medical License 1997 - 2026
PA State Medical License 1996 - 2010
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors Start of enrollment: 1998 May 01
Completed
Phase 2
Irinotecan in Treating Children With Refractory Solid Tumors Start of enrollment: 1999 Oct 01
Completed
Phase 2
Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia Start of enrollment: 2004 Jan 01
Completed
Phase 1
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.
Manuela Albisetti, Igor Tartakovsky, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers
Journal of the American Heart Association. 2024-02-20
2 citations
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.
Leonardo R Brandão, Igor Tartakovsky, Manuela Albisetti, Jacqueline Halton, Lisa Bomgaars
Blood Advances. 2022-11-22
2 citations
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials.
Lesley G Mitchell, Daniel Röshammar, Fenglei Huang, Manuela Albisetti, Leonardo R Brandão
Thrombosis and Haemostasis. 2022-09-01

Press Mentions

Texas Children's Cancer Center Alex's Lemonade Stand Center of ExcellenceSeptember 23rd, 2018